Similar articles

• Phenylpropanolamine and the risk of hemorrhagic stroke.

  Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI. Kernan WN, et al. N Engl J Med. 2000 Dec 21;343(25):1826-32. doi: 10.1056/NEJM200012213432501. N Engl J Med. 2000. PMID: 11117973
• Phenylpropanolamine and hemorrhagic stroke.

  Ernst ME, Hartz A. Ernst ME, et al. N Engl J Med. 2001 Apr 5;344(14):1094; author reply 1095. N Engl J Med. 2001. PMID: 11291667 No abstract available.
• FDA issues public health advisory on phenylpropanolamine in drug products.

  Meadows M. Meadows M. FDA Consum. 2001 Jan-Feb;35(1):9. FDA Consum. 2001. PMID: 11930934 No abstract available.
• Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.

  Mersfelder TL. Mersfelder TL. Cleve Clin J Med. 2001 Mar;68(3):208-9, 213-9, 223. doi: 10.3949/ccjm.68.3.208. Cleve Clin J Med. 2001. PMID: 11263849 Review.
• [A case with cerebral subcortical hemorrhage following the administration of phenylpropanolamine].

  Otomo S, Kubo J, Mihara B, Gomi S, Suga S. Otomo S, et al. Rinsho Shinkeigaku. 2001 Jul;41(7):407-11. Rinsho Shinkeigaku. 2001. PMID: 11808351 Review. Japanese.